Autologous serum skin test vs autologous plasma skin test in patients with chronic urticaria: Evaluation of reproducibility, sensitivity and specificity and relationship with disease activity, quality of life and anti-thyroid antibodies

European Journal of Dermatology

Volumn 21, Issue 3, 2011, Pages 339-343

  Kocatürk, Emek ^a   Kavala, Mukaddes ^a   Kural, Esra ^a   Sarigul, Sukran ^b   Zindanci, Ilkin ^a  

^a GOZTEPE TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b Fatih Sultan Mehmet Training and Research Hospital   (Turkey)

Author keywords

Anti thyroid antibodies; Autologous plasma skin test; Autologous serum skin test; Chronic urticaria; Quality of life

Indexed keywords

THYROID ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; AUTOLOGOUS PLASMA SKIN TEST; AUTOLOGOUS SERUM SKIN TEST; BLOOD EXAMINATION; CHRONIC URTICARIA; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE DURATION; FEMALE; HUMAN; IMMUNOREACTIVITY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; QUALITY OF LIFE; REPRODUCIBILITY; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SKIN TEST; URTICARIA ACTIVITY SCORE;

ADULT; CHRONIC DISEASE; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNITY, CELLULAR; ISOANTIBODIES; MALE; MIDDLE AGED; PLASMA; PROSPECTIVE STUDIES; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SERUM; SEVERITY OF ILLNESS INDEX; SKIN TESTS; URTICARIA;

EID: 79960792576     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2011.1294     Document Type: Article

References (33)

1. Greaves MW. Chronic urticaria. New Engl J Med 1995; 332: 1767-72.
2. Greaves MW. Skin diseases with high public health impact. Urticaria and angioedema. Eur J Dermatol 2008; 18: 105-6.
3. Augey F, Goujon-Henry C, Berard F, Nicolas JF, Gunera-Saad N. Is there a link between chronic urticaria and atopy? Eur J Dermatol 2008; 18: 348-9.
4. Nassif A. Is chronic urticaria an atopic condition? Eur J Dermatol 2007; 17: 545-6.
5. Maurer M. Chronic Urticaria. In: Zuberbier T, Grattan C, Maurer M (Eds). Urticaria and Angioedema. Springer-Verlag Berlin Heidelberg, 2010: 44-56.
6. Kaplan AP. Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol 2004; 114: 465-74.
7. Grattan CEH, Wallington TB, Warin RP, et al. A serological mediator in chronic idiopathic urticaria-a clinical, immunological and histological evaluation. Br J Dermatol 1986; 114: 583-90.
8. Sabroe RA, Grattan CE, Francis DM, et al. The autologous serum skin test: a screening test for autoantibodies in chronic idiopathic urticaria. Br J Dermatol 1999; 140: 446-52.
9. Asero R, Lorini M, Chong SU, Zuberbier T, Tedeschi A. Assessment of histamine releasing activity of sera from patients with chronic urticaria showing positive autologous skin test on human basophils and mast cells. Clin Exp Allergy 2004; 34: 1111-4.
10. rd ed. Philadelphia: Lippincott, Williams andWilkins; 1999: 331-47.
11. Ward PA, Hill JH. C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils. J Immunol 1970; 104: 535-43.
12. Asero R, Tedeschi A, Riboldi P, Cugno M. Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal and flare reactions much more frequently than autologous serum. J Allergy Clin Immunol 2006; 117: 1113-7.
13. Konstantinou GN, Asero R, Maurer M, Sabroe RA, Schmid-Grendelmeier P, Grattan CE. EAACI/GA(2)LEN task force consensus report: the autologous serum skin test in urticaria. Allergy 2009; 64: 1256-68.
14. Młynek A, Zalewska-Janowska A, Martus P, Staubach P, Zuberbier T, Maurer M. How to assess disease activity in patients with chronic urticaria? Allergy 2008; 63: 777-80.
15. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-6.
16. Oztürkcan S, Ermertcan AT, Eser E, Sahin MT. Cross validation of the Turkish version of dermatology life quality index. Int J Dermatol 2006; 45: 1300-7.
17. Baiardini I, Pasquali M, Braido F, et al. A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). Allergy 2005; 60: 1073-8.
18. Schaeffer RC, Gong F, Bitrick MS, Smith TL. Thrombin and bradykinin initiate discrete endothelial solute permeability mechanisms. Am J Physiol 1993; 264: 1798-809.
19. Cirino G, Cicala C, Bucci MR, Sorrentino L, maranganore JM, Stone SR. Thrombin functions as an inflammatory mediator through activation of its receptors. J Exp Med 1996; 183: 821-7.
20. Razin E, Marx G. Thrombin induced degranulation of cultured bone marrow-derived mast cells. J Immunol 1984; 133: 3282-5.
21. Godse KV. Autologous serum skin test v/s autologous plasma skin test. Indian J Dermatol Venereol Leprol 2008; 74: 496-7.
22. Metz M, Giménez-Arnau A, Borzova E, Grattan CE, Magerl M, Maurer M. Frequency and clinical implications of skin autoreactivity to serum versus plasma in patients with chronic urticaria. J Allergy Clin Immunol 2009; 123: 705-6.
23. Nettis E, Dambra P, D′Oronzio L, et al. Reactivity to autologous serum skin test and clinical features in chronic idiopathic urticaria. Clin Exp Dermatol 2002; 27: 29-31.
24. Kulthanan K, Jiamton S, Gorvanich T, Pinkaew S. Autologous serum skin test in chronic idiopathic urticaria: prevalence, correlation and clinical implications. Asian Pac J Allergy Immunol 2006; 24: 201-6.
25. Sabroe RA, Francis DM, Barr RM, Black AK, Greaves MW. Anti-Fc(episilon)RI auto antibodies and basophil histamine releasability in chronic idiopathic urticaria. J Allergy Clin Immunol 1998; 102: 6518.
26. Bakos N, Hillander M. Comparison of chronic autoimmune urticaria with chronic idiopathic urticaria. Int J Dermatol 2003; 42: 613-5.
27. O'Donnell BF, Francis DM, Swana GT, Seed PT, Kobza Black A, Greaves MW. Thyroid autoimmunity in chronic urticaria. Br J Dermatol 2005; 153: 331-5.
28. Sabroe RA, Seed PT, Francis DM, Barr RM, Black AK, Greaves MW. Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies. J Am Acad Dermatol 1999; 40: 443-50.
29. Garmendia JV, Zabaleta M, Aldrey O, et al. Immunophenotype characteristics of peripheral blood mononuclear leukocytes of chronic idiopathic urticaria patients. Invest Clin 2006; 47: 361-9.
30. De Swerdt A, Van Den Keybus C, Kasran A, et al. Detection of basophilactivating IgG autoantibodies in chronic idiopathic urticaria by induction of CD 63. J Allergy Clin Immunol 2005; 116: 662-7.
31. Staubach P, Onnen K, Vonend A, et al. Autologous whole blood injections to patients with chronic urticaria and a positive autologous serum skin test: a placebo-controlled trial. Dermatology 2006; 212: 150-9.
32. Caproni M, Volpi W, Giomi B, et al. Chronic idiopathic and chronic autoimmune urticaria: clinical and immunopathological features of 68 subjects. Acta Derm Venereol 2004; 84: 288-90.
33. Leznoff A, Sussman GL. Syndrome of idiopathic chronic urticaria and angioedema with thyroid autoimmunity: a study of 90 patients. J Allergy Clin Immunol 1989; 84: 66-71.